Musk says he has implanted a brain-computer chip in the second human
2024-08-09 16:18:29
Elon Musk announced today that Neuralink, a pioneer in brain-computer interface technology, has once again achieved a breakthrough, successfully implanting an advanced brain-computer interface chip in a second human patient. This milestone not only marks a significant progress since the first surgery in January this year, but also another miracle in the fields of medicine and technology.
Neuralink, a pioneering company founded by Musk in 2016, is committed to building a bridge between the human brain and the outside world. Its core technology is to precisely implant ultra-fine wires into the brain, which are then connected to a special chip embedded with precision electrodes that can capture signals from neuronal clusters, thus achieving unprecedented direct communication between the brain and external devices.
Earlier this year, Neuralink's first human trial shocked the world. Through this revolutionary technology, the subjects achieved a "telepathic" control experience, seamlessly controlling their phones or computers with their thoughts alone. The entire process did not require any eye tracking devices, demonstrating the profound impact of technology on future lifestyles.
Now, Neuralink's second product, Blindsight, has brought hope of regaining sight to blind patients. The product can convert external visual information into brain-computer signals and transmit them directly to the brain, allowing patients to perceive the world without physical vision.
In addition, regarding Neuralink's third product, preliminary information reveals its potential to assist paralyzed patients in rehabilitation and treat mental illness, heralding broad prospects for solving serious mental health problems and physical dysfunction in the future.
Neuralink, a pioneering company founded by Musk in 2016, is committed to building a bridge between the human brain and the outside world. Its core technology is to precisely implant ultra-fine wires into the brain, which are then connected to a special chip embedded with precision electrodes that can capture signals from neuronal clusters, thus achieving unprecedented direct communication between the brain and external devices.
Earlier this year, Neuralink's first human trial shocked the world. Through this revolutionary technology, the subjects achieved a "telepathic" control experience, seamlessly controlling their phones or computers with their thoughts alone. The entire process did not require any eye tracking devices, demonstrating the profound impact of technology on future lifestyles.
Now, Neuralink's second product, Blindsight, has brought hope of regaining sight to blind patients. The product can convert external visual information into brain-computer signals and transmit them directly to the brain, allowing patients to perceive the world without physical vision.
In addition, regarding Neuralink's third product, preliminary information reveals its potential to assist paralyzed patients in rehabilitation and treat mental illness, heralding broad prospects for solving serious mental health problems and physical dysfunction in the future.